HJ Patel, PJ Barnes, T Takahashi, S Tadjkarimi, MH Yacoub and MG Belvisi
Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.

Functional studies suggest the presence of prejunctional muscarinic autoreceptors on cholinergic nerves in human airways. However, these studies are an indirect method of evaluating changes in neurally evoked acetylcholine (ACh) release. We have investigated the presence of muscarinic autoreceptors in human and guinea pig trachea by comparing the effects of the muscarinic receptor antagonists pirenzepine (M1), methoctramine (M2), 4-DAMP (M3), and rispenzepine (M1/M3) on cholinergic neural contractile responses evoked by electrical field stimulation (EFS) and [3H]ACh release. The M1, M1/M3, or M3 antagonists inhibited the EFS-evoked cholinergic contractile response in a concentration-dependent manner (4-DAMP > rispenzepine > pirenzepine), whereas methoctramine facilitated this response at low concentrations ( < 3 microM). In ACh release studies, the M3 antagonist had no significant effect, whereas pirenzepine, methoctramine, and rispenzepine significantly increased ACh release in guinea pig trachea. In contrast, ACh release was significantly inhibited by the muscarinic agonist oxotremorine M. Methoctramine and the nonselective antagonist ipratropium bromide, but not the M1, M1/M3, or M3 antagonists, significantly increased ACh release in human trachea. These data suggest the presence of an autoinhibitory receptor on cholinergic nerve terminals in human and guinea pig trachea. In addition, the action of ipratropium bromide at the autoinhibitory receptor may limit its use in the treatment of obstructive airways disease.

This article has been cited by other articles:

				V. C. Freund-Michel, M. A. Birrell, H. J. Patel, I. M. Murray-Lyon, and M. G. Belvisi Modulation of cholinergic contractions of airway smooth muscle by cathinone: potential beneficial effects in airway diseases Eur. Respir. J., September 1, 2008; 32(3): 579 - 584. [Abstract] [Full Text] [PDF]

				F. R. Coulson, D. B. Jacoby, and A. D. Fryer Insulin Regulates Neuronal M2 Muscarinic Receptor Function in the Ileum of Diabetic Rats J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 760 - 766. [Abstract] [Full Text] [PDF]

				G. J. Rodrigo and C. Rodrigo The Role of Anticholinergics in Acute Asthma Treatment* : An Evidence-Based Evaluation Chest, June 1, 2002; 121(6): 1977 - 1987. [Abstract] [Full Text] [PDF]

				V. Oberhauser, E. Schwertfeger, T. Rutz, F. Beyersdorf, and L. C. Rump Acetylcholine Release in Human Heart Atrium : Influence of Muscarinic Autoreceptors, Diabetes, and Age Circulation, March 27, 2001; 103(12): 1638 - 1643. [Abstract] [Full Text] [PDF]

				P. J. Barnes The Pharmacological Properties of Tiotropium Chest, February 1, 2000; 117(2_suppl): 63S - 66S. [Abstract] [Full Text] [PDF]

				H. J. Patel, M. A. Giembycz, J. E. Keeling, P. J. Barnes, and M. G. Belvisi Inhibition of Cholinergic Neurotransmission in Guinea Pig Trachea by NS1619, a Putative Activator of Large-Conductance, Calcium-Activated Potassium Channels J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 952 - 958. [Abstract] [Full Text]

				R W Costello, D B Jacoby, and A D Fryer Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity Thorax, July 1, 1998; 53(7): 613 - 618. [Full Text]

				E.-B. Haddad, J. Rousell, M. A. Lindsay, and P. J. Barnes Synergy between Tumor Necrosis Factor alpha and Interleukin 1beta in Inducing Transcriptional Down-regulation of Muscarinic M2 Receptor Gene Expression. INVOLVEMENT OF PROTEIN KINASE A AND CERAMIDE PATHWAYS J. Biol. Chem., December 20, 1996; 271(51): 32586 - 32592. [Abstract] [Full Text] [PDF]